Acrescent (memantine hydrochloride;donepezil hydrochloride)
- Region
- 🇪🇺 EU
- Active substance
- memantine hydrochloride;donepezil hydrochloride
- Company
- H. Lundbeck A/S
- Status
- Refused
- Therapeutic area
- Alzheimer Disease
- CHMP opinion
- Thu 18 Oct 2012
- Application
- EMEA/H/C/002424
- ATC
- N06D
- Official record
- www.ema.europa.eu
Indication
Treatment of Alzheimers disease
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Balaxur Refused · Merz Pharmaceuticals GmbH
Follow Acrescent
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.